Danish C25 index falls 0.4% as Zealand Pharma gains fail to offset losses from DSV, Mærsk, and Novo
By
MarketWire
Leave it on the tray for the seagulls.
Summary
The Danish elite index C25 fell 0.4% to 1734.94 on Tuesday, despite gains from Zealand Pharma and Novonesis. Heavyweights DSV, Mærsk, and Novo Nordisk dragged the index down. An investment director notes the composition of Danish companies explains the divergence from European and US markets, with attention now turning to upcoming US inflation data expected to rise in May.
Key quotes
· 2 pulledDet er sammensætningen af de danske selskaber, der gør, at vi ikke går helt samme vej
Inflationen ventes at stige i maj…
You might also wanna read

Denmark Eliminates 25% Book Tax to Address Reading Crisis
Denmark's government is eliminating its 25% sales tax on books, which is currently the highest in Europe, in response to concerns about a "r
Danish Pension Fund AkademikerPension Blacklists SpaceX Over Valuation and Governance Concerns
AkademikerPension, a $25 billion Danish pension fund, has blacklisted SpaceX from its investment portfolio, citing the company as "grossly o
Danish Pension Fund AkademikerPension Blacklists SpaceX Over Valuation and Governance Concerns
AkademikerPension, a $25 billion Danish pension fund, has blacklisted SpaceX from its investment portfolio, citing the company as "grossly o
Danish Pension Fund AkademikerPension Blacklists SpaceX Over Valuation and Governance Concerns
AkademikerPension, a $25 billion Danish pension fund, has blacklisted SpaceX from its investment portfolio, citing the company as "grossly o
Danish pension fund divesting US Treasuries
Danish pension fund excludes SpaceX citing governance and valuation
Study Finds Ozempic Does Not Slow Alzheimer's Disease Progression
Novo Nordisk announced that its popular weight-loss drug Ozempic does not slow the progression of Alzheimer's disease, based on results from
